WHO Member States Advance Key Annex to Pandemic Agreement
Michael Gwarisa After a week of intensive discussions on the draft annex for Pathogen Access and Benefit Sharing (PABS), countries around the world have outlined a clear roadmap to implement the pandemic agreement effectively. The PABS framework is an essential part of the WHO Pandemic Agreement. It is designed to ensure fair and timely access
Read More
Africa CDC and FHI 360 Sign MoU to Strengthen Health Security and Advance Africa’s Health Sovereignty
Michael Gwarisa In a move aimed at strengthening collaboration to advance health security, workforce development, and resilient public health systems across Africa, the Africa Centres for Disease Control and Prevention has signed a Memorandum of Understanding (MoU) with FHI 360. The MoU sets in motion a structured framework for cooperation aligned with Africa CDC’s Strategic
Read More
Guchu Manufacturer Under Fire for Using MCAZ Logo
Michael Gwarisa A daring local manufacturer of a herbal aphrodisiac, known as Hubaba, has come under fire for using the Medicines Control Authority of Zimbabwe (MCAZ) logo without the organisation’s consent. MCAZ is responsible for registering pharmaceutical products and consumables in Zimbabwe. However, a growing trend has emerged where herbal merchants and manufacturers falsely claim
Read More
Zimbabwe Approves Contingency Fund to Strengthen Seasonal Disease Response
Kuda Pembere Zimbabwe’s Cabinet has approved a Contingency Fund for the Ministry of Health and Child Care to bolster its readiness and response to seasonal disease outbreaks. Speaking to journalists during a Post-Cabinet Media Briefing, Information Minister Dr Soda Zhemu explained that the fund aims to improve the Ministry’s capacity to respond swiftly to emerging
Read More
What the Science Says About Lenacapavir, Its Effectiveness, Side Effects and Zimbabwe’s HIV Prevention Push
Michael Gwarisa Zimbabwe has set the stage for the rollout of Lenacapavir, a long acting injectable HIV prevention medicine that is expected to significantly strengthen the country’s HIV response. The injectable drug, which is administered only twice a year, is being introduced as part of Zimbabwe’s expanded HIV prevention strategy targeting people at high risk
Read More